James N. Livingston - Concepedia

Author

James N. Livingston

Also Known As

A. R. Clocquet, J Livingston, J N Livingston, J. N. Livingston, J.N. Livingston, JAMES N. LIVINGSTON, James Livingston, James N Livingston, James N. Livingston

122

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

University of Rochester Bayer (United States)Johns Hopkins Medicine Johns Hopkins University Karolinska Institutet

About

James N. Livingston is an author at University of Rochester specializing in medicine, physiology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	51	3.3K
2	Health Sciences	22	31	1.8K
3	Business	4	4	152
4	Natural Sciences	4	4	192
5	Engineering	1	1	23

James N. Livingston

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity Morris F. White, James N. Livingston, Jonathan Backer, Cell Insulin SignalingMolecular PhysiologySignal TransductionG Protein-coupled ReceptorMedicine	1988	370
Distribution of insulin receptor-like immunoreactivity in the rat forebrain J. Unger, T.H. McNeill, Richard T. Moxley, Neuroscience PhysiologyDiabetesRat ForebrainNervous SystemMedicine	1989	297
Small-Molecule Ghrelin Receptor Antagonists Improve Glucose Tolerance, Suppress Appetite, and Promote Weight Loss William P. Esler, Joachim Rudolph, Thomas H. Claus, Endocrinology NutritionFood IntakeGlucose ToleranceInsulin SignalingSuppress Appetite	2007	227
Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway Juleen R. Zierath, James N. Livingston, Anders Thörne, Diabetologia ObesityMetabolic SyndromeBiochemistryMedicineRegional Difference	1998	218
Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitus Peter Arner, Thomas Pollare, Hans Lithell, Diabetologia ObesityMetabolic SyndromeInsulin ResistanceKinesiologySkeletal Muscle	1987	179
Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity Joachim Rudolph, William P. Esler, Stephen O’Connor, Journal of Medicinal Chemistry Food IntakePharmacotherapyType 1AInsulin SignalingGastrointestinal Peptide Hormone	2007	157
A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal Manami Tsutsumi, Thomas H. Claus, Yin Liang, Diabetes Insulin SignalingGastrointestinal Peptide HormoneMolecular PharmacologyInsulin DeliveryDiabetes Management	2002	124
Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. Jinbao Ren, Pei-Ming Li, W R Zhang, Diabetes Transgenic Mice DeficientGlucose HomeostasisInsulin SignalingMetabolic SyndromeReceptor Tyrosine Kinase	1998	120
Insulin Signaling in Mice Expressing Reduced Levels of Syp Joanne M. Arrandale, Ann Gore-Willse, Sandra Rocks, Journal of Biological Chemistry	1996	102
Studies of glucagon resistance in large rat adipocytes: 125I-labeled glucagon binding and lipolytic capacity James N. Livingston, Pedro Cuatrecasas, Dean H. Lockwood Journal of Lipid Research	1974	96

Page 1